DRD2 and Parkinson disease: Hence, the obtained results support a multimodal dopamine-adenosine approach for PD management: selectively targeting the D2R-A2AR oligomerization status via combined pharmacotherapeutic strategies could restore the unbalanced D2R-A2AR oligomer function associated with PD.